Download PDF
Semin Speech Lang 2017; 38(03): 191-199
DOI: 10.1055/s-0037-1602838
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Examining Variation in Treatment Outcomes among Speakers with Dysarthria

Annalise Fletcher
1   Department of Communication Disorders, University of Canterbury, Canterbury, New Zealand
2   New Zealand Institute of Language, Brain and Behaviour, New Zealand.
,
Megan McAuliffe
1   Department of Communication Disorders, University of Canterbury, Canterbury, New Zealand
2   New Zealand Institute of Language, Brain and Behaviour, New Zealand.
› Author Affiliations
Further Information

Publication History

Publication Date:
15 June 2017 (online)

    Permissions and Reprints

Abstract

Studies investigating the outcomes of behavioral treatments for dysarthria commonly focus on group-level effects. Individual differences in treatment response have received less attention. Currently, we have limited understanding of why some speakers respond favorably to certain intervention programs but others do not. This article advocates for a more individualized approach to assessing the efficacy of speech pathology intervention. A conceptual framework is presented, in which the effects of salient speech features and contextual factors upon treatment outcomes are considered statistically, with a view to informing treatment planning and development of future clinical studies. Preliminary evidence is presented in support of this framework—demonstrating that detailed measurements of the speech signal can predict which individuals respond favorably to certain treatment cues, even among participants with the same dysarthria etiology and subtype. Future directions for the study of individualized assessment and treatment approaches are discussed.

Keywords

Dysarthria - prognosis - individualized treatment - acoustic analysis
 

  • References

  • 1 Morgan AT, Vogel AP. Intervention for dysarthria associated with acquired brain injury in children and adolescents. Cochrane Database Syst Rev 2008; 3 (03) CD006279
    PubMedGoogle Scholar
  • 2 Herd CP, Tomlinson CL, Deane KH. , et al. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane Database Syst Rev 2012; 8 (08) CD002812
    PubMedGoogle Scholar
  • 3 Sellars C, Hughes T, Langhorne P. Speech and language therapy for dysarthria due to non-progressive brain damage. Cochrane Database Syst Rev 2005; (03) CD002088
    PubMedGoogle Scholar
  • 4 Baylor CR, Yorkston KM. Using systematic reviews and practice guidelines: a how-to guide for clinicians. SIG 2 . Perspect Neurophysiol Neurogenic Speech Lang Disord 2007; 17 (01) 6-10
    PubMedGoogle Scholar
  • 5 Palmer R, Enderby P. Methods of speech therapy treatment for stable dysarthria: A review. Adv Speech Lang Pathol 2007; 9 (02) 140-153
    PubMedGoogle Scholar
  • 6 Atkinson-Clement C, Sadat J, Pinto S. Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature. Neurodegener Dis Manag 2015; 5 (03) 233-248
    CrossrefPubMedGoogle Scholar
  • 7 Herd CP, Tomlinson CL, Deane KHO. , et al. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease. Cochrane Database Syst Rev 2012; (08) CD002814
    PubMedGoogle Scholar
  • 8 Hanson EK, Yorkston KM, Britton D. Dysarthria in amyotrophic lateral sclerosis: a systematic review of characteristics, speech treatment, and augmentative and alternative communication options. J Med Speech-Lang Pathol 2011; 19 (03) 12
    PubMedGoogle Scholar
  • 9 Kim Y, Kent RD, Weismer G. An acoustic study of the relationships among neurologic disease, dysarthria type, and severity of dysarthria. J Speech Lang Hear Res 2011; 54 (02) 417-429
    CrossrefPubMedGoogle Scholar
  • 10 Cannito MP, Suiter DM, Beverly D, Chorna L, Wolf T, Pfeiffer RM. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease. J Voice 2012; 26 (02) 214-219
    CrossrefPubMedGoogle Scholar
  • 11 Lowit A, Dobinson C, Timmins C, Howell P, Kröger B. The effectiveness of traditional methods and altered auditory feedback in improving speech rate and intelligibility in speakers with Parkinson's disease. Int J Speech-Language Pathol 2010; 12 (05) 426-436
    PubMedGoogle Scholar
  • 12 Pennington L, Miller N, Robson S, Steen N. Intensive speech and language therapy for older children with cerebral palsy: a systems approach. Dev Med Child Neurol 2010; 52 (04) 337-344
    CrossrefPubMedGoogle Scholar
  • 13 Duffy JR. Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. St. Louis, MO: Elsevier Health Sciences; 2013
    Google Scholar
  • 14 Weismer G, Kim Y-J. Classification and taxonomy of motor speech disorders: What are the issues?. In: Maassen B, van Lieshout PHHM. , eds. Speech Motor Control: New Developments in Basic and Applied Research. Cambridge, UK: Oxford University Press; 2010: 229-241
    Google Scholar
  • 15 Park S, Theodoros D, Finch E, Cardell E. Be clear: a new intensive speech treatment for adults with nonprogressive dysarthria. Am J Speech Lang Pathol 2016; 25 (01) 97-110
    CrossrefPubMedGoogle Scholar
  • 16 Tompkins CA, Jackson ST, Schulz R. On prognostic research in adult neurologic disorders. J Speech Hear Res 1990; 33 (02) 398-401
    CrossrefPubMedGoogle Scholar
  • 17 Dignam J, Copland D, O'Brien K, Burfein P, Khan A, Rodriguez AD. Influence of cognitive ability on therapy outcomes for anomia in adults with chronic poststroke aphasia. J Speech Lang Hear Res 2017; 60 (02) 406-421
    CrossrefPubMedGoogle Scholar
  • 18 De Ryck A, Brouns R, Fransen E. , et al. A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra 2013; 3 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 19 Miller N, Noble E, Jones D, Allcock L, Burn DJ. How do I sound to me? Perceived changes in communication in Parkinson's disease. Clin Rehabil 2008; 22 (01) 14-22
    CrossrefPubMedGoogle Scholar
  • 20 Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 2013; 12 (04) 368-380
    CrossrefPubMedGoogle Scholar
  • 21 Wenke RJ, Cornwell P, Theodoros DG. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria. Int J Speech-Language Pathol 2010; 12 (03) 203-220
    PubMedGoogle Scholar
  • 22 Palmer R, Enderby P, Hawley M. Addressing the needs of speakers with longstanding dysarthria: computerized and traditional therapy compared. Int J Lang Commun Disord 2007; 42 (Suppl. 01) 61-79
    CrossrefPubMedGoogle Scholar
  • 23 Fox CM, Morrison CE, Ramig LO, Sapir S. Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease. Am J Speech Lang Pathol 2002; 11 (02) 111
    CrossrefPubMedGoogle Scholar
  • 24 D'Innocenzo J, Tjaden K, Greenman G. Intelligibility in dysarthria: effects of listener familiarity and speaking condition. Clin Linguist Phon 2006; 20 (09) 659-675
    CrossrefPubMedGoogle Scholar
  • 25 Fox CM, Boliek CA. Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria. J Speech Lang Hear Res 2012; 55 (03) 930-945
    CrossrefPubMedGoogle Scholar
  • 26 Ramig LO, Countryman S, O'Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques. Neurology 1996; 47 (06) 1496-1504
    CrossrefPubMedGoogle Scholar
  • 27 Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatr Logop 2002; 54 (06) 296-303
    CrossrefPubMedGoogle Scholar
  • 28 Mackenzie C, Lowit A. Behavioural intervention effects in dysarthria following stroke: communication effectiveness, intelligibility and dysarthria impact. Int J Lang Commun Disord 2007; 42 (02) 131-153
    CrossrefPubMedGoogle Scholar
  • 29 Hammen VL, Yorkston KM, Minifie FD. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria. J Speech Hear Res 1994; 37 (02) 244-253
    CrossrefPubMedGoogle Scholar
  • 30 Pilon MA, McIntosh KW, Thaut MH. Auditory vs visual speech timing cues as external rate control to enhance verbal intelligibility in mixed spastic-ataxic dysarthric speakers: a pilot study. Brain Inj 1998; 12 (09) 793-803
    CrossrefPubMedGoogle Scholar
  • 31 Van Nuffelen G, De Bodt M, Wuyts F, Van de Heyning P. The effect of rate control on speech rate and intelligibility of dysarthric speech. Folia Phoniatr Logop 2009; 61 (02) 69-75
    CrossrefPubMedGoogle Scholar
  • 32 Van Nuffelen G, De Bodt M, Vanderwegen J, Van de Heyning P, Wuyts F. Effect of rate control on speech production and intelligibility in dysarthria. Folia Phoniatr Logop 2010; 62 (03) 110-119
    CrossrefPubMedGoogle Scholar
  • 33 Nasreddine ZS, Phillips NA, Bédirian V. , et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
    CrossrefPubMedGoogle Scholar
  • 34 Beck AT, Steer RA, Brown GK. Beck depression inventory. NCTSN 1996; 11: 57
    PubMedGoogle Scholar
  • 35 Multon KD, Brown SD, Lent RW. Relation of self-efficacy beliefs to academic outcomes: A meta-analytic investigation. Journal of Counseling Psychology 1991; 38 (01) 30-38
    CrossrefPubMedGoogle Scholar
  • 36 Jensen MP, Turner JA, Romano JM. Self-efficacy and outcome expectancies: relationship to chronic pain coping strategies and adjustment. Pain 1991; 44 (03) 263-269
    CrossrefPubMedGoogle Scholar
  • 37 Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway JA. University of Washington self-efficacy scale: a new self-efficacy scale for people with disabilities. Arch Phys Med Rehabil 2012; 93 (10) 1757-1765
    CrossrefPubMedGoogle Scholar
  • 38 Fletcher A, McAuliffe M, Lansford K, Sinex D, Liss J. Predicting intelligibility gains in individuals with dysarthria from baseline speech features. J Speech Lang Hear Res, In press
    PubMedGoogle Scholar
  • 39 Bayestehtashk A, Asgari M, Shafran I, McNames J. Fully automated assessment of the severity of Parkinson's disease from speech. Comput Speech Lang 2015; 29 (01) 172-185
    CrossrefPubMedGoogle Scholar
  • 40 Berisha V, Sandoval S, Utianski R, Liss J, Spanias A. Selecting disorder-specific features for speech pathology fingerprinting. Conference: Proceedings IEEE Int Conf Acoust Speech Signal Process. Vancouver, BC, Canada; May 26–31 2013. Doi: 10.1109/ICASSP.2013.6639133 2013
    PubMedGoogle Scholar
  • 41 Wisler A, Berisha V, Liss J, Spanias A. Domain invariant speech features using a new divergence measure. Conference: Spoken Language Technology Workshop (SLT) 2014 IEEE. South Lake Tahoe, NV, December 7–10, 2014
    PubMedGoogle Scholar
  • 42 Liss JM, LeGendre S, Lotto AJ. Discriminating dysarthria type from envelope modulation spectra. J Speech Lang Hear Res 2010; 53 (05) 1246-1255
    CrossrefPubMedGoogle Scholar
  • 43 Sandoval S, Berisha V, Utianski RL, Liss JM, Spanias A. Automatic assessment of vowel space area. J Acoust Soc Am 2013; 134 (05) EL477-EL483
    CrossrefPubMedGoogle Scholar
  • 44 Jiao Y, Berisha V, Tu M, Liss J. Convex weighting criteria for speaking rate estimation. IEEE/ACM Transact Audio Speech Lang Process 2015; 23 (09) 1421-1430
    PubMedGoogle Scholar
  • 45 Fletcher A, Wisler A, McAuliffe M, Lansford K, Liss J. Predicting intelligibility gains in dysarthria through automated speech feature analysis: a follow-up study. J Speech Lang Hear Res, In press
    PubMedGoogle Scholar
  • 46 Constantinescu G, Theodoros D, Russell T, Ward E, Wilson S, Wootton R. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial. Int J Lang Commun Disord 2011; 46 (01) 1-16
    PubMedGoogle Scholar